Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT07671495
What this trial is testing

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Who this might be right for
Melanoma Stage IMelanoma Stage IIIMelanoma Stage II+1 more
MIPO Clinic 278
Large-scale testing (Phase 3)Active Not RecruitingNCT00003641
What this trial is testing

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,150
Early research (Phase 1)Study completedNCT00112242
What this trial is testing

Immunotherapy of Stage III/IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 39
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Early research (Phase 1)Study completedNCT00527761
What this trial is testing

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

Who this might be right for
Metastatic Melanoma
M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Testing effectiveness (Phase 2)Study completedNCT00466687
What this trial is testing

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 34
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT02875132
What this trial is testing

Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma

Who this might be right for
Acral Lentiginous Melanoma
Chinese University of Hong Kong 9
Next Page